One possibility is the lab prioritized other clients' samples leading to a delay in reporting for PNN. Labs will pander to 'better' clients (larger, more money, higher sample volume, longer relationship)...can't really blame them as it makes commercial sense. Given Li in Argentina is hot right now I'm sure there were/are plenty of companies pushing hard for results. Mistake in PNN's update on 13 December was creating an expectation assays would be received before the end of last year; vague timelines can be annoying for investors but are 'safer' for companies.
PNN Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
